Programme overview

08:00

CxO breakfast meeting: for CEOs, CFOs, COOs and CBOs active in the life sciences sector

Limited places are available and only to MT members from (R&D) life sciences companies who are attending the conference.

08:00

Investors forum part 1 - breakfast session -

The investors forum is an exciting opportunity for those companies looking for equity capital and/or partnerships with companies and institutes across the life sciences value chain, from biotech, med tech and pharma companies to financiers and universities. The forum offers excellent opportunities for presenting your company or university to all major Dutch life sciences investors and discuss your business strategy, technology direction and capital-raising plan.

08:45

Registration and information desk open

08:45

Exhibition and Innovation square

Present your company, products, technology or service. Open from 08:45 till 18:30 hours.

09:30

Plenary morning programme

Hosted by Leiden Bio Science Park

• Welcome by chair Eline Vrijland-van Beest
  

  Eline is chairing the plenary programme of the conference and will guide us through the day.

• Opening
  

  by Pancras Hogendoorn, Dean, vice-chairman of the executive board at the Leiden University Medical Center (LUMC)

• Keynote lecture about rapid and cost-effective manufacturing solutions in the development of vaccines
  

  by Menzo Havenga, President & CEO Batavia Biosciences

  There is a constant demand for more affordable vaccines for global health (polio, measles, rubella), as well as new vaccines to protect against emerging virus outbreaks, such as Ebola, Lassa, Marburg, and coronavirus. To keep up with such demand, breakthrough technologies and global collaborations are required that allow flexible, cost-effective and rapid vaccine development. In this presentation, promising novel technologies, flexible manufacturing solutions and views on collaborations within the industry will be presented. These innovations have demonstrated to substantially lower the cost of goods and increase speed of manufacturing. Such innovations are deemed critical to stay ahead of the game and keep millions of people from dying from vaccine preventable diseases.

• Venture Challenge
  

  Hosted by Health~Holland, Dr. ir. C.G.P. (Chrétien) Herben, Manager Valorisation 

  With a presentation by André van de Sande, advisor to the Pivot Park and partner of the Venture Challenge programme.
  The winner of the Venture Challenge Fall 2020 will be announced!

10:45

Break

Time for networking and to visit the exhibition and innovation square.

11:15

12:30

Lunch

Time for networking and to visit the exhibition and innovation square.

12:30

Investors forum part 2 - lunch session -

13:30

14:45

Break

Time for networking and to visit the exhibition and innovation square.

15:30

Wrap up parallel sessions

15:40

Closing plenary programme

• Announcement winner Investors Forum
  

  The winner of the Investors Forum will be awarded a partnering ticket, national or international with a total value of EUR 2,500 and will present their pitch.

• Keynote lecture
  

  Hanneke Schuitemaker, Professor in Virology and VP Viral Vaccine Discovery & Translational Medicine at Janssen Vaccines & Prevention will give insights in the development of the Covid-19 vaccine at Janssen Vaccines in Leiden. 

17:00

Reception

Drinks, bites and networking.
Exhibition and innovation square open.